Rick Adler, DVM, PHD, DACVP

Dr. Adler is a board-certified veterinary pathologist with more than 35 years of large Pharma company drug discovery and development experience.  Throughout his career, he applied Pathology, Toxicology, and aligned scientific disciplines to advance innovative medicine portfolios from earliest target idea stage through registration and post approval lifecycle management, inclusive of numerous due diligence and regulatory interactions across that spectrum.  Immediately prior to joining Aclairo in 2023, he retired from GlaxoSmithKline after 18 years as US Head of Discovery and Regulatory Pathology and has also learned from multiple roles growing his career, and applying his leadership skills and strategic agility toward problem-solving and scientific issue resolution with Pfizer, Marion Merrell Dow, and MPI Research as Study Director, Study Pathologist, Therapeutic Area Leader, and serving in multiple senior management roles.  His experience covers diverse therapeutic areas including cardiovascular, metabolic, immune and infectious disease, neuroscience, dermatology, and oncology.